Statement Of Cash Flows [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for deferred tax expense |
79,651
EUR
|
62,895
EUR
|
| Cash flows from (used in) operations before changes in working capital |
140,434
EUR
|
88,488
EUR
|
| Increase (decrease) in working capital |
182,069
EUR
|
71,836
EUR
|
| Adjustments for decrease (increase) in trade and other receivables |
29,823
EUR
|
34,751
EUR
|
| Adjustments for increase (decrease) in trade and other payables |
191,813
EUR
|
141,160
EUR
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
32,199
EUR
|
80,102
EUR
|
| Adjustments for undistributed profits of investments accounted for using equity method |
3,360
EUR
|
4,048
EUR
|
| Cash flows from (used in) investing activities [abstract] | ||
| Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets |
156,335
EUR
|
267,834
EUR
|
| Proceeds from disposals of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets |
880,000
EUR
|
436,000
EUR
|
| Cash flows from (used in) financing activities [abstract] | ||
| Proceeds from issue of bonds, notes and debentures |
581,763
EUR
|
0
EUR
|
| Repayments of bonds, notes and debentures |
236,431
EUR
|
0
EUR
|